Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yu-Teng Ma, Xiao-Fang Xing, Bin Dong, Xiao-Jing Cheng, Ting Guo, Hong Du, Xian-Zi Wen & Jia-Fu Ji. (2018) Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer. Cancer Management and Research 10, pages 4969-4980.
Read now
Read now
Articles from other publishers (68)
Guanqiao Chen, Xiaoshan Hong, Wanshan He, Lingling Ou, Bin Chen, Weitao Zhong, Yu Lin & Xiping Luo. (2023) The construction and analysis of tricarboxylic acid cycle related prognostic model for cervical cancer. Frontiers in Genetics 14.
Crossref
Crossref
Ammara Riaz, Rabia Zara, Gul Bushra, Nazia Kanwal, Ayesha Sadiqa, Farzana Shareef, Iqra Sarfraz, Muhammad Ajmal Shah, Ilknur Ucak, Shazia Anwer Bukhari & Azhar Rasul. 2022. The Role of Phytonutrients in Metabolic Disorders. The Role of Phytonutrients in Metabolic Disorders
237
290
.
Lama Ahmad, Stéphane Plancqueel, Noureddine Lazar, Hafsa Korri-Youssoufi, Inès Li de la Sierra-Gallay, Herman van Tilbeurgh & Laurent Salmon. (2020) Novel N-substituted 5-phosphate-d-arabinonamide derivatives as strong inhibitors of phosphoglucose isomerases: Synthesis, structure-activity relationship and crystallographic studies. Bioorganic Chemistry 102, pages 104048.
Crossref
Crossref
Marion Devillers, Jean‐Philip Piquemal, Laurent Salmon & Nohad Gresh. (2020) Calibration of the dianionic phosphate group: Validation on the recognition site of the homodimeric enzyme phosphoglucose isomerase. Journal of Computational Chemistry 41:8, pages 839-854.
Crossref
Crossref
Lama Ahmad, Laurent Salmon & Hafsa Korri-Youssoufi. (2019) Electrochemical detection of the human cancer biomarker ‘autocrine motility factor-phosphoglucose isomerase’ based on a biosensor formed with a monosaccharidic inhibitor. Sensors and Actuators B: Chemical 299, pages 126933.
Crossref
Crossref
D. A. Korshunov, I. V. Kondakova & E. E. Shashova. (2019) Modern Perspective on Metabolic Reprogramming in Malignant Neoplasms. Biochemistry (Moscow) 84:10, pages 1129-1142.
Crossref
Crossref
Tiago MA. Carvalho, Henrique J. Cardoso, Marília I. Figueira, Cátia V. Vaz & Sílvia Socorro. (2019) The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy. European Journal of Medicinal Chemistry 171, pages 343-363.
Crossref
Crossref
Lautaro Gándara & Pablo Wappner. (2018) Metabo-Devo: A metabolic perspective of development. Mechanisms of Development 154, pages 12-23.
Crossref
Crossref
Shao Thing Teoh & Sophia Y. Lunt. (2017) Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond. WIREs Systems Biology and Medicine 10:2.
Crossref
Crossref
Mansi Arora & Deepak KaulMansi Arora & Deepak Kaul. 2018. Cancer RNome: Nature & Evolution. Cancer RNome: Nature & Evolution
113
242
.
Marion Devillers, Lama Ahmad, Hafsa Korri-Youssoufi & Laurent Salmon. (2017) Carbohydrate-based electrochemical biosensor for detection of a cancer biomarker in human plasma. Biosensors and Bioelectronics 96, pages 178-185.
Crossref
Crossref
Hahn-Sun Jung, Su In Lee, Seung-Hoon Kang, Jin Sang Wang, Eun Hee Yang, Byungwook Jeon, Jayhyuk Myung, Ji Young Baek & Song-Kyu Park. (2017) Monoclonal antibodies against autocrine motility factor suppress gastric cancer. Oncology Letters 13:6, pages 4925-4932.
Crossref
Crossref
Zhuomin Lyu, Yibing Chen, Xu Guo, Feng Zhou, Zhaoyong Yan, Jinliang Xing, Jiaze An & Hongxin Zhang. (2016) Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 40:6, pages 698-704.
Crossref
Crossref
Arti T. Patel, Rekha C. Akhani, Manisha J. Patel, Samir R. Dedania & Darshan H. Patel. (2016) Biochemical Leaning of Phosphoglucose Isomerase is More Towards Gluconeogenesis in Pseudomonas aeruginosa PAO1. Asian Journal of Biochemistry 11:3, pages 118-126.
Crossref
Crossref
D. A. Korshunov & I. V. Kondakova. Effect of anti-glycolytic agents on tumour cells in vitro. Effect of anti-glycolytic agents on tumour cells in vitro.
Ming Zong, Tianbao Lu, Shasha Fan, Hui Zhang, Ruhan Gong, Lishan Sun, Zhiyan Fu & Lieying Fan. (2015) Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Research & Therapy 17:1.
Crossref
Crossref
Yiran Li, Yuanhui Jia, Qi Che, Qian Zhou, Kai Wang & Xiao-Ping Wan. (2015) AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma. Oncotarget 6:28, pages 26373-26387.
Crossref
Crossref
H Lincet & P Icard. (2014) How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?. Oncogene 34:29, pages 3751-3759.
Crossref
Crossref
Juan Bayo, Esteban Fiore, Jorge B. Aquino, Mariana Malvicini, Manglio Rizzo, Estanislao Peixoto, Oscar Andriani, Laura Alaniz, Flavia Piccioni, Marcela Bolontrade, Osvaldo Podhajcer, Mariana G. Garcia & Guillermo Mazzolini. (2014) Increased Migration of Human Mesenchymal Stromal Cells by Autocrine Motility Factor (AMF) Resulted in Enhanced Recruitment towards Hepatocellular Carcinoma. PLoS ONE 9:4, pages e95171.
Crossref
Crossref
Xiaojin Wang, Lijiao Zhang, Fengyun Gu, Xiaojie Zhang & Ning Xia. (2013) Investigation of the Interaction between Ferroceneboronic Acid and Sugars and Its Application in Probing of Enzyme Activity. International Journal of Electrochemical Science 8:12, pages 12557-12565.
Crossref
Crossref
Wen‐Ling Shih, Feng‐Ling Yu, Ching‐Dong Chang, Ming‐Huei Liao, Hung‐Yi Wu & Ping‐Yuan Lin. (2012)
Suppression of
AMF
/
PGI
‐mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model
. Molecular Carcinogenesis 52:10, pages 800-812.
Crossref
Crossref
Dhong Hyo Kho, Pratima Nangia-Makker, Vitaly Balan, Victor Hogan, Larry Tait, Yi Wang & Avraham Raz. (2013) Autocrine Motility Factor Promotes HER2 Cleavage and Signaling in Breast Cancer Cells. Cancer Research 73:4, pages 1411-1419.
Crossref
Crossref
Takashi Yanagawa. (2012) Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor. Oncology Reports.
Crossref
Crossref
Carlotta Granchi & Filippo Minutolo. (2012) Anticancer Agents That Counteract Tumor Glycolysis. ChemMedChem 7:8, pages 1318-1350.
Crossref
Crossref
Ilknur Melis Durasi, Ugur Dag, Burcu Bakir Gungor, Burcu Erdogan, Isil Aksan Kurnaz & O. Ugur Sezerman. (2011) Identification of transcription factor binding sites in promoter databases. Identification of transcription factor binding sites in promoter databases.
Yasufumi Niinaka, Kiyoshi Harada, Masahiro Fujimuro, Masamitsu Oda, Arayo Haga, Misa Hosoki, Narikazu Uzawa, Naoya Arai, Satoshi Yamaguchi, Masashi Yamashiro & Avraham Raz. (2010) Silencing of Autocrine Motility Factor Induces Mesenchymal-to-Epithelial Transition and Suppression of Osteosarcoma Pulmonary Metastasis. Cancer Research 70:22, pages 9483-9493.
Crossref
Crossref
Zvi RappoportLi‐June Ming. 2010. Patai's Chemistry of Functional Groups. Patai's Chemistry of Functional Groups.
Wen-Ling Shih, Ming-Huei Liao, Ping-Yuan Lin, Chi-I Chang, Hsueh-Ling Cheng, Feng-Ling Yu & Jeng-Woei Lee. (2010) PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-β-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase. Cancer Letters 290:2, pages 223-237.
Crossref
Crossref
Jorge F. Haller, Conor Smith, Dailan Liu, Hongying Zheng, Keith Tornheim, Gil-Soo Han, George M. Carman & Raphael A. Zoeller. (2010) Isolation of Novel Animal Cell Lines Defective in Glycerolipid Biosynthesis Reveals Mutations in Glucose-6-phosphate Isomerase. Journal of Biological Chemistry 285:2, pages 866-877.
Crossref
Crossref
Tatsuyoshi Funasaka, Victor Hogan & Avraham Raz. (2009) Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer. Cancer Research 69:13, pages 5349-5356.
Crossref
Crossref
S. Yeluri, B. Madhok, K. R. Prasad, P. Quirke & D. G. Jayne. (2009) Cancer’s craving for sugar: an opportunity for clinical exploitation. Journal of Cancer Research and Clinical Oncology 135:7, pages 867-877.
Crossref
Crossref
Kiruthika Balasubramanian, Raghavendra Vasudevamurthy, Sathisha Upparahalli Venkateshaiah, Anil Thomas, A. Vishweshwara & Shylaja Mallaiah Dharmesh. (2008) Galectin-3 in urine of cancer patients: stage and tissue specificity. Journal of Cancer Research and Clinical Oncology 135:3, pages 355-363.
Crossref
Crossref
Hua-Yang Lin, Ya-Heui Kao, Shu-Ting Chen & Menghsiao Meng. (2009) Effects of inherited mutations on catalytic activity and structural stability of human glucose-6-phosphate isomerase expressed in Escherichia coli. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1794:2, pages 315-323.
Crossref
Crossref
Maria Fairbank, Pascal St-Pierre & Ivan R. Nabi. (2009) The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase. Molecular BioSystems 5:8, pages 793.
Crossref
Crossref
Megumi Iiizumi, Wen Liu, Sudha K. Pai, Eiji Furuta & Kounosuke Watabe. (2008) Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1786:2, pages 87-104.
Crossref
Crossref
Wen-Ling Shih, Ming-Huei Liao, Feng-Ling Yu, Ping-Yuan Lin, Hsue-Yin Hsu & Shu-Jun Chiu. (2008) AMF/PGI transactivates the MMP-3 gene through the activation of Src-RhoA-phosphatidylinositol 3-kinase signaling to induce hepatoma cell migration. Cancer Letters 270:2, pages 202-217.
Crossref
Crossref
Liliana D. Kojic, Sam M. Wiseman, Fariba Ghaidi, Bharat Joshi, Hinyu Nedev, H. Uri Saragovi & Ivan R. Nabi. (2008) Raft-Dependent Endocytosis of Autocrine Motility Factor/Phosphoglucose Isomerase: A Potential Drug Delivery Route for Tumor Cells. PLoS ONE 3:10, pages e3597.
Crossref
Crossref
Tatsuyoshi Funasaka & Avraham Raz. 2008. Regulation of Gene Expression in the Tumor Environment. Regulation of Gene Expression in the Tumor Environment
11
25
.
Tatsuyoshi Funasaka, Huankai Hu, Victor Hogan & Avraham Raz. (2007) Down-regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Expression Sensitizes Human Fibrosarcoma Cells to Oxidative Stress Leading to Cellular Senescence. Journal of Biological Chemistry 282:50, pages 36362-36369.
Crossref
Crossref
Tatsuyoshi Funasaka & Avraham Raz. (2007) The role of autocrine motility factor in tumor and tumor microenvironment. Cancer and Metastasis Reviews 26:3-4, pages 725-735.
Crossref
Crossref
Takashi Yanagawa, Tatsuyoshi Funasaka, Soichi Tsutsumi, Huankai Hu, Hideomi Watanabe & Avraham Raz. (2007) Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Activities by the Poly(ADP-Ribose) Polymerase Family-14. Cancer Research 67:18, pages 8682-8689.
Crossref
Crossref
Tatsuyoshi Funasaka, Huankai Hu, Takashi Yanagawa, Victor Hogan & Avraham Raz. (2007) Down-Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Results in Mesenchymal-to-Epithelial Transition of Human Lung Fibrosarcoma Cells. Cancer Research 67:9, pages 4236-4243.
Crossref
Crossref
Wei Wang, Lian-Yue Yang, Zhi-Li Yang, Ji-Xiang Peng & Jie-Quan Yang. (2007) Elevated Expression of Autocrine Motility Factor Receptor Correlates with Overexpression of RhoC and Indicates Poor Prognosis in Hepatocellular Carcinoma. Digestive Diseases and Sciences 52:3, pages 770-775.
Crossref
Crossref
Y Dobashi, H Watanabe, Y Sato, S Hirashima, T Yanagawa, H Matsubara & A Ooi. (2006) Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas. The Journal of Pathology 210:4, pages 431-440.
Crossref
Crossref
Monica Schaller, William Stohl, Vivian Benoit, Soon-Min Tan, Lene Johansen & Henrik J. Ditzel. (2006) Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI). Biochemical and Biophysical Research Communications 349:2, pages 838-845.
Crossref
Crossref
H Pelicano, D S Martin, R-H Xu & P Huang. (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25:34, pages 4633-4646.
Crossref
Crossref
Yoh Dobashi, Hideomi Watanabe, Maki Matsubara, Takashi Yanagawa, Avraham Raz, Tamiyasu Shimamiya & Akishi Ooi. (2005) Autocrine motility factor/glucose‐6‐phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours. The Journal of Pathology 208:1, pages 44-53.
Crossref
Crossref
Tatsuyoshi Funasaka, Takashi Yanagawa, Victor Hogan & Avraham Raz. (2005) Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. The FASEB Journal 19:11, pages 1422-1430.
Crossref
Crossref
Takashi Yanagawa, Tatsuyoshi Funasaka, Soichi Tsutsumi, Tirza Raz, Nobutada Tanaka & Avraham Raz. (2005) Differential Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Activities by Protein Kinase CK2 Phosphorylation. Journal of Biological Chemistry 280:11, pages 10419-10426.
Crossref
Crossref
Arayo HAGA. (2005) A Possibility that AMF will Serve as a Target Molecule for the Diagnosis and Treatment in a Metastatic NeoplasmAutocrine Motility Factorは転移腫瘍における診断•治療のターゲット分子となり得るか. YAKUGAKU ZASSHI 125:2, pages 169-175.
Crossref
Crossref
Hong Gao, Ye Chen & Julie A. Leary. (2005) Kinetic measurements of phosphoglucose isomerase and phosphomannose isomerase by direct analysis of phosphorylated aldose–ketose isomers using tandem mass spectrometry. International Journal of Mass Spectrometry 240:3, pages 291-299.
Crossref
Crossref
Gary P Richards, Carl H Hammer, Mark K Garfield & Salina Parveen. (2004) Characterization of a lysyl aminopeptidase activity associated with phosphoglucose isomerase of Vibrio vulnificus. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1700:2, pages 219-229.
Crossref
Crossref
Suresh Mishra, Avrahram Raz & Liam J. Murphy. (2004) Insulin-Like Growth Factor Binding Protein-3 Interacts with Autocrine Motility Factor/Phosphoglucose Isomerase (AMF/PGI) and Inhibits the AMF/PGI Function. Cancer Research 64:7, pages 2516-2522.
Crossref
Crossref
Takashi Yanagawa, Hideomi Watanabe, Toshiyuki Takeuchi, Shuhei Fujimoto, Hideyuki Kurihara & Kenji Takagishi. (2004) Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-β. Laboratory Investigation 84:4, pages 513-522.
Crossref
Crossref
Feng-Ling Yu, Ming-Huei Liao, Jeng-Woei Lee & Wen-Ling Shih. (2004) Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3. Biochemical and Biophysical Research Communications 314:1, pages 76-82.
Crossref
Crossref
Soichi Tsutsumi, Takashi Yanagawa, Tatsuo Shimura, Tomoharu Fukumori, Victor Hogan, Hiroyuki Kuwano & Avraham Raz. (2003) Regulation of Cell Proliferation by Autocrine Motility Factor/Phosphoglucose Isomerase Signaling. Journal of Biological Chemistry 278:34, pages 32165-32172.
Crossref
Crossref
Y. Niinaka, A. Haga, A. Negishi, H. Yoshimasu, A. Raz & T. Amagasa. (2002) Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells. Oral Oncology 38:1, pages 49-55.
Crossref
Crossref
Yasuharu Onishi, Arayo Haga & Avraham Raz. 2002. Cancer Metastasis — Related Genes. Cancer Metastasis — Related Genes
109
122
.
Jizu Zhi, Dirk W. Sommerfeldt, Clinton T. Rubin & Michael Hadjiargyrou. (2009) Differential Expression of Neuroleukin in Osseous Tissues and Its Involvement in Mineralization During Osteoblast Differentiation. Journal of Bone and Mineral Research 16:11, pages 1994-2004.
Crossref
Crossref
Tatsuyoshi Funasaka, Arayo Haga, Avraham Raz & Hisamitsu Nagase. (2001) Tumor Autocrine Motility Factor Is an Angiogenic Factor That Stimulates Endothelial Cell Motility. Biochemical and Biophysical Research Communications 285:1, pages 118-128.
Crossref
Crossref
Jon Read, Jake Pearce, Xiaochun Li, Hilary Muirhead, John Chirgwin & Christopher Davies. (2001) The crystal structure of human phosphoglucose isomerase at 1.6 Å resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia. Journal of Molecular Biology 309:2, pages 447-463.
Crossref
Crossref
Tatsuyoshi Funasaka, Arayo Haga, Avraham Raz & Hisamitsu Nagase. (2001) Tumor Autocrine Motility Factor Is an Angiogenic Factor That Stimulates Endothelial Cell Motility. Biochemical and Biophysical Research Communications 284:5, pages 1116-1125.
Crossref
Crossref
Chia-Cheng Chou, Yuh-Ju Sun, Menghsiao Meng & Chwan-Deng Hsiao. (2000) The Crystal Structure of Phosphoglucose Isomerase/Autocrine Motility Factor/Neuroleukin Complexed with Its Carbohydrate Phosphate Inhibitors Suggests Its Substrate/Receptor Recognition. Journal of Biological Chemistry 275:30, pages 23154-23160.
Crossref
Crossref
Arayo Haga, Yasufumi Niinaka & Avraham Raz. (2000) Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1480:1-2, pages 235-244.
Crossref
Crossref
Annick Lagana, Thomas Duchaine, Avraham Raz, Luc DesGroseillers & Ivan R. Nabi. (2000) Expression of Autocrine Motility Factor/Phosphohexose Isomerase in Cos7 Cells. Biochemical and Biophysical Research Communications 273:1, pages 213-218.
Crossref
Crossref
Wilfried Kugler & Max Lakomek. (2000) Glucose-6-phosphate isomerase deficiency. Best Practice & Research Clinical Haematology 13:1, pages 89-101.
Crossref
Crossref
Yuh-Ju SunChia-Cheng ChouWei-Shone ChenRong-Tsun WuMenghsiao MengChwan-Deng Hsiao. (1999) The crystal structure of a multifunctional protein: Phosphoglucose isomerase/autocrine motility factor/neuroleukin. Proceedings of the National Academy of Sciences 96:10, pages 5412-5417.
Crossref
Crossref
Steve Silletti, Sandor Paku & Avraham Raz. (1997) Tumor cell motility and metastasis. Pathology & Oncology Research 3:3, pages 230-254.
Crossref
Crossref